 
                                  Anticoagulants and Immunosuppressives in Behçet’s Syndrome
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
By Arisa Chuklin, Thita Joy Chiasakul, and Noppacharn Uaprasert
• Context: Behçet’s syndrome is a systemic vasculitis often complicated by venous or arterial thrombosis, yet the optimal role of anticoagulation remains uncertain.
• Study: Across 20 studies (315 patients with disaggregated data), this meta-analysis compared relapse rates under immunosuppressives, anticoagulants, or both.
• Findings: Combination therapy markedly reduced thrombosis relapse (17.7%) versus immunosuppressives alone (43.7%) or anticoagulants alone (54.9%), supporting a dual-modality approach for vascular Behçet’s.”
Title: Anticoagulants and immunosuppressive therapy for thrombosis in Behçet’s syndrome: a systematic review and meta-analysis
Authors: Arisa Chuklin, Thita Chiasakul, Noppacharn Uaprasert

Read the article here.
Stay updated on all scientific advances with Hemostasis Today.
- 
                    Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
- 
                    Oct 30, 2025, 03:53Michael Makris on Biomarin's Decision to Divest Roctavian
- 
                    Oct 29, 2025, 10:39UMR1011 Researchers at ECTH 2025
- 
                    Oct 29, 2025, 07:09Hritvik Jain and Andrew Goldsweig Sharedrisk About the Risk of MACCE, AMI, and readmission in IBD patients undergoing PCI
- 
                    Oct 29, 2025, 07:07Flora Peyvandi Shared an Article About Menstrual Bleeding and Bleeding Tendency in Dutch Adolescents
- 
                    Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
- 
                    Oct 29, 2025, 07:18Osimertinib Has Transformed Lung Cancer Care — But at What Cost to the Heart?
- 
                    Oct 29, 2025, 07:15From the Lab to Prague․ Our ECTH 2025 Experience
- 
                    Oct 29, 2025, 07:13Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
- 
                    Oct 29, 2025, 07:09Davide Capodanno: This Time It’s About the Timing of Complete Revascularization in ACS
- 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
- 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
- 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
- 
                    Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
- 
                    Oct 27, 2025, 09:19Mitra Najafi: Digital Storage Device - Specifically Designed and Developed to Store and Preserve PRP
- 
                    Oct 30, 2025, 11:56Lucas de Vries Defends His PHD Combining Physics, Deep Learning and Medical Imaging
- 
                    Oct 30, 2025, 03:50Laura Bouvet Receives the Young Investigator Award at ECTH 2025
- 
                    Oct 29, 2025, 08:30ECTH 2025․ Advancing the Science of Thrombosis and Haemostasis Together
- 
                    Oct 28, 2025, 06:59Wim van den Broek Attended ECTH in Prague
- 
                    Oct 28, 2025, 06:46Alexandre Kauskot Attended ECTH in Prague
